Mary Beth Wire

Phase I Dose Escalation Trial Evaluating the Pharmacokinetics, Anti-Human Cytomegalovirus (HCMV) Activity, and Safety of 1263W94 in Human Immunodeficiency Virus-Infected Men with Asymptomatic HCMV Shedding

Jacob Lalezari, Judith A. Aberg, Laurene H. Wang et al. · Antimicrobial Agents and Chemotherapy · 2002 · 151 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I Safety and Pharmacokinetic Trials of 1263W94, a Novel Oral Anti-Human Cytomegalovirus Agent, in Healthy and Human Immunodeficiency Virus-Infected Subjects

Laurene H. Wang, Richard Peck, Yin Yin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 134 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studies

Daphne Williams, Bin Peng, Christine K. Bailey et al. · Clinical Therapeutics · 2009 · 88 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers

Alicia J. Allred, Carolyn J. Bowen, Jung Wook Park et al. · British Journal of Clinical Pharmacology · 2011 · 71 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Metabolism and Disposition of Eltrombopag, an Oral, Nonpeptide Thrombopoietin Receptor Agonist, in Healthy Human Subjects

Yanli Deng, Armina Madatian, Mary Beth Wire et al. · Drug Metabolism and Disposition · 2011 · 56 citations

Pharmacy, Pharmacokinetics, Pharmacology +11